JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.

Setting

Ordered before 17:30, shipped today - Support: (012) 800 456 789

Track Your Order

Home
Search results for: 'bax inhibitor peptide negative control'

Search results for: 'bax inhibitor peptide negative control'

A5096 PF-04217903

Target: c-MET

Summary: C-Met inhibitor,selective and ATP-competitive

insoluble in EtOH; insoluble in H2O; ≥18.6 mg/mL
A8476 MK-2461

Target: FLT3|PDGFR|MET|Ron

Summary: C-Met (WT/mutants) inhibitor

≥24.8 mg/mL
A4326 TAK-700 (Orteronel)

2 Citation

Target: human lyase

Summary: Human 17,20-lyase inhibitor

insoluble in H2O; ≥11.2 mg/mL
A8325 Tivantinib (ARQ 197)

2 Citation

Target: MET

Summary: C-Met inhibitor,non-ATP-competitive

≥18.47 mg/mL
A8322 Neratinib (HKI-272)

1 Citation

Target: EGFR

Summary: HER2/EGFR inhibitor,potent and irreversible

insoluble in H2O; ≥13.93 mg/mL
A1903 E 64d

4 Citation

Summary: Cysteine protease inhibitor

insoluble in H2O; ≥17.12 mg/mL
B4890 HPOB

1 Citation

Target: Histone Deacetylases (HDACs)

Summary: HDAC6 inhibitor, potent and selective

≥31.4 mg/mL
A3965 BI 2536

1 Citation

Target: PLK|Bromodomain-containing proteins(BRDs)

Summary: Plk1 inhibitor,potent and ATP-competitive

insoluble in H2O; ≥13.04 mg/mL
B1112 Merimepodib

Target: IMPDH

Summary: Novel noncompetitive inhibitor of IMPDH(Inosine monophosphate dehydrogenase).

≥45.2 mg/mL
A4009 CEP-18770

1 Citation

Summary: Proteasome inhibitor

insoluble in H2O; ≥16.75 mg/mL